Smiths Group (LON:SMIN)‘s stock had its “overweight” rating restated by equities research analysts at JPMorgan Chase & Co. in a report released on Monday. They currently have a GBX 1,800 ($24.41) price objective on the stock. JPMorgan Chase & Co.’s price objective points to a potential upside of 7.43% from the stock’s current price.

A number of other analysts have also issued reports on SMIN. Goldman Sachs Group reaffirmed a “buy” rating and set a GBX 1,850 ($25.09) target price on shares of Smiths Group in a research report on Friday, September 22nd. Numis Securities reaffirmed a “hold” rating and set a GBX 1,600 ($21.70) target price on shares of Smiths Group in a research report on Monday, September 25th. reaffirmed a “buy” rating and set a GBX 1,900 ($25.77) target price on shares of Smiths Group in a research report on Friday, September 29th. Credit Suisse Group reaffirmed an “outperform” rating on shares of Smiths Group in a research report on Friday, October 13th. Finally, Deutsche Bank reaffirmed a “buy” rating and set a GBX 1,750 ($23.73) target price on shares of Smiths Group in a research report on Monday, December 4th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of GBX 1,770 ($24.00).

Smiths Group (SMIN) traded up GBX 21 ($0.28) during trading hours on Monday, hitting GBX 1,673 ($22.69). 2,180,000 shares of the stock were exchanged, compared to its average volume of 1,020,000. Smiths Group has a 12 month low of GBX 1,442 ($19.56) and a 12 month high of GBX 1,685 ($22.85). The company has a market cap of $6,620.00 and a price-to-earnings ratio of 1,178.17.

In related news, insider George Buckley bought 1,111 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was bought at an average cost of GBX 1,577 ($21.39) per share, for a total transaction of £17,520.47 ($23,759.79).

ILLEGAL ACTIVITY NOTICE: “Smiths Group’s (SMIN) “Overweight” Rating Reaffirmed at JPMorgan Chase & Co.” was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/15/smiths-groups-smin-overweight-rating-reaffirmed-at-jpmorgan-chase-co.html.

Smiths Group Company Profile

Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.

Analyst Recommendations for Smiths Group (LON:SMIN)

Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with MarketBeat.com's FREE daily email newsletter.